BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10476588)

  • 1. Use of N-acetylcysteine in the management of coronary artery diseases.
    Marchetti G; Lodola E; Licciardello L; Colombo A
    Cardiologia; 1999 Jul; 44(7):633-7. PubMed ID: 10476588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects.
    Simon K; Szépvölgyi A
    Circulation; 1996 Oct; 94(7):1791. PubMed ID: 8840884
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris.
    Ardissino D; Merlini PA; Savonitto S; Demicheli G; Zanini P; Bertocchi F; Falcone C; Ghio S; Marinoni G; Montemartini C; Mussini A
    J Am Coll Cardiol; 1997 Apr; 29(5):941-7. PubMed ID: 9120179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate.
    Kelly EA; Ahmed RM; Horowitz JD
    Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting.
    Koramaz I; Pulathan Z; Usta S; Karahan SC; Alver A; Yaris E; Kalyoncu NI; Ozcan F
    Ann Thorac Surg; 2006 Feb; 81(2):613-8. PubMed ID: 16427861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury.
    Kizilgun M; Poyrazoglu Y; Oztas Y; Yaman H; Cakir E; Cayci T; Akgul OE; Kurt YG; Yaren H; Kunak ZI; Macit E; Ozkan E; Taslipinar MY; Turker T; Ozcan A
    Ren Fail; 2011; 33(5):512-7. PubMed ID: 21545313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
    Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Smith TW; Antman EM
    Circulation; 1988 Apr; 77(4):787-94. PubMed ID: 3127076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of N-acetylcysteine.
    Kelly GS
    Altern Med Rev; 1998 Apr; 3(2):114-27. PubMed ID: 9577247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction.
    Yesilbursa D; Serdar A; Senturk T; Serdar Z; Sağ S; Cordan J
    Heart Vessels; 2006 Jan; 21(1):33-7. PubMed ID: 16440146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery.
    Fischer UM; Tossios P; Huebner A; Geissler HJ; Bloch W; Mehlhorn U
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):103-8. PubMed ID: 15224028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial ischemia-reperfusion injury and melatonin].
    Sahna E; Deniz E; Aksulu HE
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):163-8. PubMed ID: 16766282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetylcysteine in bronchitis and pneumonia].
    Vogelmeier C
    Internist (Berl); 1999 Oct; 40(10):1102-3. PubMed ID: 10610368
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
    Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
    Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
    J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic use of N-acetylcysteine in acute lung diseases].
    Domenighetti G; Quattropani C; Schaller MD
    Rev Mal Respir; 1999 Feb; 16(1):29-37. PubMed ID: 10091258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.